Physician profile
Michael Reynolds
NPI 1760486526
$731.81
in general payments reported to CMS, 2019-2025
12 companies · $22.73 in 2025
The $22.73 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $82.56 · 2021: $96.05 · 2022: $75.99 · 2023: $192 · 2024: $125 · 2025: $22.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $339.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $394.08 | 2019-2025 | Clareon, Acrysof Iq Panoptix Uv Iol, Argos |
| Bard Peripheral Vascular, INC. | $96.05 | 2021 | |
| Allergan, INC. | $65.00 | 2019 | |
| Horizon Therapeutics Plc | $46.10 | 2023 | Tepezza |
| Carl Zeiss Meditec, INC. | $24.90 | 2020 | |
| Aerie Pharmaceuticals, INC. | $21.68 | 2020 | |
| Amgen INC. | $20.21 | 2024 | Tepezza |
| Acadia Pharmaceuticals INC | $17.40 | 2023 | Nuplazid |
| Biotissue Holdings INC. | $16.40 | 2023 | |
| Kala Pharmaceuticals, INC. | $13.09 | 2019 | |
| Vantage Technology LLC | $10.69 | 2023 | |
| The Cameron-Ehlen Group, INC. | $6.21 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Reynolds listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.